Related Experiment Videos

Bladder augmentation surgery--what about the malignant risk?

J Shaw1, M A Lewis

  • 1The North West Regional Spina Bifida Registry, Manchester Children's Hospitals, Pendlebury, UK.

Insights

Augmentation cystoplasty for neuropathic bladder is common, but carries malignancy risks. UK surgeons perform over 150 procedures annually and advocate for a central registry to track patients and outcomes.

Area of Science:

  • Pediatric Urology
  • Surgical Oncology

Background:

  • Augmentation cystoplasty is a frequent surgical solution for neuropathic bladder.
  • Malignancy risk in bladder augmentations is a known complication, estimated at 1.3% over time.

Purpose of the Study:

  • To determine the annual number of bladder augmentations performed in children in the UK.
  • To assess if surgeons inform patients/parents about the malignancy risks associated with this surgery.

Main Methods:

  • A survey was distributed to 36 UK pediatric surgeons specializing in pediatric urology.
  • The survey aimed to gather data on the frequency of bladder augmentation surgeries and risk disclosure practices.

Main Results:

  • Over 150 bladder augmentation procedures are performed annually in UK children.
  • Surveyed surgeons expressed concern regarding malignancy risks and largely supported establishing a Central Registry.

Conclusions:

  • There is a significant volume of bladder augmentation surgeries performed in UK children.
  • A consensus exists among pediatric urologists regarding the need for a Central Registry to monitor long-term outcomes and risks.

Related Concept Videos